The Case for Improved Diagnostic Tools to Control Ebola Virus Disease in West Africa and How to Get There

Open Access

The Policy Platform is for authors to discuss policies that could improve the lives of those at risk of, or affected by, the NTDs.

Arlene C. Chua ,

* E-mail: Arlene.Chua@geneva.msf.org

Affiliations Medécins Sans Frontières, Access Campaign, Geneva, Switzerland, Department of Infectious Diseases, Institute of Infectious Diseases and Epidemiology, Singapore
⨯
Jane Cunningham,

Affiliation Global Malaria Programme, World Health Organization, Geneva, Switzerland
⨯
Francis Moussy,

Affiliation Department of Essential Medicines and Health Products, World Health Organization, Geneva, Switzerland
⨯
Mark D. Perkins,

Affiliation Foundation for Innovative New Diagnostics, Geneva, Switzerland
⨯
Pierre Formenty

Affiliation Department of Pandemic and Epidemic Diseases, World Health Organization, Geneva, Switzerland
⨯

Reader Comments (0)

Diagnostic medicine
Is the Subject Area "Diagnostic medicine" applicable to this article?

Thanks for your feedback.
Virus testing
Is the Subject Area "Virus testing" applicable to this article?

Thanks for your feedback.
Ebola virus
Is the Subject Area "Ebola virus" applicable to this article?

Thanks for your feedback.
Government laboratories
Is the Subject Area "Government laboratories" applicable to this article?

Thanks for your feedback.
Ebola hemorrhagic fever
Is the Subject Area "Ebola hemorrhagic fever" applicable to this article?

Thanks for your feedback.
Health care facilities
Is the Subject Area "Health care facilities" applicable to this article?

Thanks for your feedback.
Epidemiology
Is the Subject Area "Epidemiology" applicable to this article?

Thanks for your feedback.
Medical personnel
Is the Subject Area "Medical personnel" applicable to this article?

Thanks for your feedback.